Skip to main content
High RiskFDAfda-F-1342-2019OTHER

All Juice Drinks and Beverages in 12 ounce glass bottles including but not limited to Agony, Double Trouble, Front End Lifter, Irish (sea...

Category
Units Affected
38
Recall Date
April 15, 2019
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1342-2019.

FDA Issued Shutdown Letter ordering the recall of all produced juices in violation of Consent Decree of Injunction

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1342-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Juices International, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1342-2019.

Juices International, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Juices International, Inc. Recall FAQ

Juices International, Inc. is the subject of a beverages safety report: All Juice Drinks and Beverages in 12 ounce glass bottles including but not limited to Agony, Double Trouble, Front End Lifter, Irish (sea.... The notice was published on April 15, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 38 units are potentially affected.